Imunon, Inc. — Director's Dealing 2024

Sep 10, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2024-09-10

Reporting Person: Lindborg Stacy (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-06	Stock Option (Right to Buy)	$1.04	A	63602	Acquired	2034-09-06	Common Stock (63602)	Direct

Footnotes

F1: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2: The options vest as follows 1/2 on the date of grant; 1/4 on the one year anniversary of the grant; and 1/4 on the second anniversary of the date of grant.

F3: Option granted in lieu of cash payment increases.